Follow

Elicera Therapeutics AB

Nasdaq First North GM (Sweden)

Elicera Therapeutics AB is a clinical stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments.

Sector:
HEALTH CARE
>
Pharmaceuticals & Biotechnology
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
ELIC
SE0015382080
Nasdaq First North GM
Sweden (SE)
Details of share in Elicera Therapeutics AB with ticker ELIC
Status
Active
Order book id
Amount of instruments
12 032 000
Par value
Currency
SEK
First trading date
11 Jun 2021
Type
Price
Pre-money
Time
Files
IPO
8.00 SEK
96.26M SEK
24 May - 08 Jun 2021
IPO in Elicera Therapeutics AB
Type
Ticker
ISIN
Market
OPTION
ELIC TO1
SE0015988233
Nasdaq First North GM
Sweden (SE)
Details of option in Elicera Therapeutics AB with ticker ELIC TO1
Status
Active
Order book id
Amount of instruments
Currency
SEK
First trading date
11 Jun 2021
Terms
Two (2) warrants entitles the holder to subscribe for one (1) new share for SEK 11.60 during the period November 1, 2022 - November 30, 2022.
Type
Price
Pre-money
Time
Files
Exercise
11.60 SEK
01 Nov - 30 Nov 2022
Option exercise terms for ELIC TO1
People
Jamal El-Mosleh
CEO
Agneta Edberg
Chairman of the board
Christina Herder
Board member
Jan Zetterberg
Board member
Margareth Jorvid
Board member
Magnus Essand
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Övre Utsiktsvägen 3
Zip code
438 34
City/district
Landvetter
Country
Sweden (SE)
Registration number
556966-4955
LEI code
549300I35L0R4INBFG27
First trade date
11 Jun 2021
Registration date
26 Mar 2014
Short name
Elicera

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More